Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Methadone Rapid Restart Study
NCT07546396Phase 4Not yet recruiting
- Sponsor
- Pouya Azar Teb
- Start
- May 2026
- Primary completion
- Mar 2027
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 4, open-label trial of methadone in opioid use disorder (OUD) (2 arms), sponsored by Pouya Azar Teb. Primary endpoints: Enrollment rate and Patient Satisfaction at Day 7. Planned start May 2026; status: not yet recruiting.
02
Drugs
methadone
03
Conditions
opioid use disorder (OUD)
Beyond the preview
Go deeper on NCT07546396.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07546396.